Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
Arjen M. Dondorp, Caterina Fanello, Ilse C. E. Hendriksen, Ermelinda Gomes, Amir Seni, Kajal Chhaganlal, Kalifa Bojang, Rasaq Olaosebikan, Nkechinyere Anunobi, Kathryn Maitland, Esther Kivaya, Tsiri Agbenyega, Samuel Blay Nguah, Jennifer Evans, Samwel Gesase, Catherine Kahabuka, George Mtove, Behzad Nadjm, Jacqueline Deen, Juliet Mwanga‐Amumpaire, Margaret Nansumba, Corine Karema, Noella Umulisa, Aline Uwimana, Olugbenga Ayodeji Mokuolu, Olanrewaju T. Adedoyin, Wahab BR Johnson, Antoinette Tshefu, Marie Onyamboko, Tharisara Sakulthaew, Wirichada Pan‐ngum, Kamolrat Silamut, Kasia Stepniewska, Charles J. Woodrow, Delia Bethell, Bridget Wills, Martina Oneko, Tim Peto, Lorenz von Seidlein, Nicholas Day, Sir Nicholas White (2010). Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. The Lancet, 376(9753), pp. 1647-1657, DOI: 10.1016/s0140-6736(10)61924-1.
